Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.

Orkin AM, Gill PJ, Ghersi D, Campbell L, Sugarman J, Emsley R, Steg PG, Weijer C, Simes J, Rombey T, Williams HC, Wittes J, Moher D, Richards DP, Kasamon Y, Getz K, Hopewell S, Dickersin K, Wu T, Ayala AP, Schulz KF, Calleja S, Boutron I, Ross JS, Golub RM, Khan KM, Mulrow C, Siegfried N, Heber J, Lee N, Kearney PR, Wanyenze RK, Hróbjartsson A, Williams R, Bhandari N, Jüni P, Chan AW, CONSERVE Group

Open source

DOI: 10.1001/jama.2021.9941
Published: 2021 Jul 20
Container: JAMA
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jama.2021.9941,
  title = {Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.},
  author = {Orkin AM and Gill PJ and Ghersi D and Campbell L and Sugarman J and Emsley R and Steg PG and Weijer C and Simes J and Rombey T and Williams HC and Wittes J and Moher D and Richards DP and Kasamon Y and Getz K and Hopewell S and Dickersin K and Wu T and Ayala AP and Schulz KF and Calleja S and Boutron I and Ross JS and Golub RM and Khan KM and Mulrow C and Siegfried N and Heber J and Lee N and Kearney PR and Wanyenze RK and Hróbjartsson A and Williams R and Bhandari N and Jüni P and Chan AW and CONSERVE Group},
  year = {2021},
  journal = {JAMA},
  doi = {10.1001/jama.2021.9941},
  url = {https://doi.org/10.1001/jama.2021.9941}
}

RIS

TY  - JOUR
TI  - Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.
AU  - Orkin AM
AU  - Gill PJ
AU  - Ghersi D
AU  - Campbell L
AU  - Sugarman J
AU  - Emsley R
AU  - Steg PG
AU  - Weijer C
AU  - Simes J
AU  - Rombey T
AU  - Williams HC
AU  - Wittes J
AU  - Moher D
AU  - Richards DP
AU  - Kasamon Y
AU  - Getz K
AU  - Hopewell S
AU  - Dickersin K
AU  - Wu T
AU  - Ayala AP
AU  - Schulz KF
AU  - Calleja S
AU  - Boutron I
AU  - Ross JS
AU  - Golub RM
AU  - Khan KM
AU  - Mulrow C
AU  - Siegfried N
AU  - Heber J
AU  - Lee N
AU  - Kearney PR
AU  - Wanyenze RK
AU  - Hróbjartsson A
AU  - Williams R
AU  - Bhandari N
AU  - Jüni P
AU  - Chan AW
AU  - CONSERVE Group
PY  - 2021
JO  - JAMA
DO  - 10.1001/jama.2021.9941
UR  - https://doi.org/10.1001/jama.2021.9941
ER  -

APA

AM, O., PJ, G., D, G., L, C., J, S., R, E., PG, S., C, W., J, S., T, R., HC, W., J, W., D, M., DP, R., Y, K., K, G., S, H., K, D., T, W., AP, A., KF, S., S, C., I, B., JS, R., RM, G., KM, K., C, M., N, S., J, H., N, L., PR, K., RK, W., A, H., R, W., N, B., P, J., AW, C., & Group, C. (2021). Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 Statement.. JAMA. https://doi.org/10.1001/jama.2021.9941

Source records

pubmed · retrieved 2026-09-26T04:14:31.863Z